Finance

Lists
Q2 2026 earnings • released • EPS beat +8.82% • Revenue miss -1.47%
See results
TDOC:NYSE
Teladoc Health Inc
$6.70
-0.15%
(-0.010) 1D
Aug 3, 3:40:09 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TDOC...
Open
$6.71
High
$6.79
Low
$6.56
Mkt. cap
1.21B
Avg. vol.
5.43M
Volume
4.63M
52-wk high
$9.89
52-wk low
$4.40
EPS
-$0.99
Beta
2.10
Shares outstanding
181.68M
No. of employees
5K
Open
$6.71
High
$6.79
Low
$6.56
Mkt. cap
1.21B
Avg. vol.
5.43M
Volume
4.63M
52-wk high
$9.89
52-wk low
$4.40
EPS
-$0.99
Beta
2.10
Shares outstanding
181.68M
No. of employees
5K
News stories
From sources across the web
Profile
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services. The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025. Wikipedia
About Teladoc Health Inc
CEO-
Employees5.12K
Founded2002
Headquarters-
SectorHealth care
Websiteteladochealth.com
Analyst ratings
Based on 17 analysts giving stock ratings to TDOC in the past 3 months
Hold
Buy
4
Hold
13
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for TDOC in the last 3 months.
Highest
Current $6.70
$10.50 (+56.72%)
Average
$7.62 (+13.73%)
Lowest
$5.50 (-17.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Grosslight
Citi
Hold
Maintained
$7.50
+11.9%
08/03/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
$6.00
-10.4%
07/30/2026
Jailendra Singh
Truist Financial
Hold
Maintained
-
-
07/30/2026
Brian Tanquilut
Jefferies
Hold
Maintained
$8.00
+19.4%
07/30/2026
David Grossman
Stifel Nicolaus
Hold
Maintained
$5.50
-17.9%
07/30/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$7.50
+11.9%
07/30/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
$10.50
+56.7%
07/30/2026
Sean Dodge
BMO Capital
Hold
Reiterated
$7.00
+4.5%
07/29/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$10.00
+49.3%
07/29/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$10.00
+49.3%
07/30/2026
Ryan MacDonald
Needham
Hold
Reiterated
-
-
07/30/2026
David Larsen
BTIG
Hold
Reiterated
-
-
07/29/2026
Peter Warendorf
Barclays
Hold
Maintained
$7.00
+4.5%
07/30/2026
Ryan Daniels
William Blair
Hold
Reiterated
-
-
07/29/2026
David Roman
Goldman Sachs
Buy
Maintained
$8.00
+19.4%
05/27/2026
Kevin Caliendo
UBS
Hold
Maintained
$6.00
-10.4%
05/15/2026
Charles Rhyee
TD Cowen
Hold
Reiterated
$6.00
-10.4%
05/04/2026
Lisa Gill
J.P. Morgan
Hold
Reiterated
$7.00
+4.5%
03/13/2026
George Hill
Deutsche Bank
Buy
Upgraded
$11.00
+64.2%
03/10/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$7.00
+4.5%
03/03/2026
Scott Schoenhaus
KeyBanc
Hold
Maintained
-
-
02/27/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
$6.00
-10.4%
02/26/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
$9.00
+34.3%
02/26/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.20 / -$0.22
+8.82%beat
Revenue / Est. (USD)
606.93M / 615.99M
-1.47%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
626.44M
642.27M
613.84M
606.93M
Cost of goods sold
187.18M
197.05M
197.53M
190.84M
Cost of revenue
187.18M
197.05M
197.53M
190.84M
Research and development expenses
67.57M
71.61M
67.86M
62.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
318.78M
305.74M
304.90M
296.82M
Operating expense
474.72M
472.19M
465.05M
450.59M
Total operating expenses
661.90M
669.24M
662.57M
641.42M
Operating income
-35.46M
-26.97M
-48.73M
-34.50M
Other non operating income
-815.00K
378.00K
-196.00K
-2.19M
EBT including unusual items
-50.22M
-33.62M
-60.84M
-37.91M
EBT excluding unusual items
-33.72M
-24.59M
-47.80M
-35.32M
Income tax expense
-715.00K
-8.48M
3.00M
997.00K
Effective tax rate
1.42%
25.21%
-4.92%
-2.63%
Other operating expenses
-
-
-
-
Net income
-49.51M
-25.14M
-63.84M
-38.91M
Net profit margin
-7.90%
-3.91%
-10.40%
-6.41%
Earnings per share
-0.19
-0.10
-0.28
-0.20
Interest and investment income
7.08M
6.95M
6.49M
6.48M
Interest expense
-4.53M
-4.95M
-5.37M
-5.11M
Net interest expenses
2.56M
2.00M
1.12M
1.37M
Depreciation and amortization charges
2.61M
2.80M
2.46M
2.47M
EBITDA
10.68M
28.67M
5.48M
19.73M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps